Global Influenza A Vaccine Market Research Report 2025(Status and Outlook)

March 2025 | 158 pages | ID: G5F500D4AA1FEN
Bosson Research

Abstracts

Report Overview

Influenza A vaccine is a preventive measure designed to protect individuals against the influenza A virus, a common and highly contagious respiratory illness that can lead to severe complications and even death, particularly among vulnerable populations such as the elderly, young children, and individuals with underlying health conditions. The vaccine works by stimulating the immune system to produce antibodies against specific strains of the influenza A virus, reducing the likelihood of infection and minimizing the severity of symptoms if infection does occur. Influenza A vaccines are typically updated annually to match the circulating strains of the virus, making them an essential tool in controlling seasonal outbreaks and mitigating the impact of influenza on public health.

The market for influenza A vaccines is influenced by several key trends and market drivers. Firstly, the increasing awareness of the importance of vaccination in preventing infectious diseases, coupled with government initiatives and public health campaigns promoting immunization, is driving demand for influenza A vaccines. Additionally, the growing global population, particularly in regions with high population densities and limited access to healthcare, is expanding the potential market for influenza A vaccines. Moreover, advancements in vaccine technology, such as the development of more effective and longer-lasting formulations, are enhancing the appeal of influenza A vaccines among healthcare providers and consumers. At the same time, the ongoing research and development efforts aimed at improving vaccine efficacy, safety, and accessibility are expected to further drive market growth in the coming years.

This report provides a deep insight into the global Influenza A Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Influenza A Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Influenza A Vaccine market in any manner.

Global Influenza A Vaccine Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Novartis

Sanofi

GSK

Medimmune

Abbott

Mitsubishi Tanabe Pharma

Merck

Sinovac Biotech

Hualan Biological Engineering

Changsheng Bio-Technology

Beijing Tiantan Bio-Products

Market Segmentation (by Type)

Intramuscular Vaccine

Nasal Spray Vaccine

Market Segmentation (by Application)

3-18 Years Old

Above 18 Years Old

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Influenza A Vaccine Market
• Overview of the regional outlook of the Influenza A Vaccine Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Influenza A Vaccine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Influenza A Vaccine
1.2 Key Market Segments
1.2.1 Influenza A Vaccine Segment by Type
1.2.2 Influenza A Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Influenza A Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Influenza A Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Influenza A Vaccine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Influenza A Vaccine Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Influenza A Vaccine Product Life Cycle
3.3 Global Influenza A Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Influenza A Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Influenza A Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Influenza A Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Influenza A Vaccine Manufacturing Sites, Area Served, Product Type
3.8 Influenza A Vaccine Market Competitive Situation and Trends
3.8.1 Influenza A Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Influenza A Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Influenza A Vaccine Industry Chain Analysis
4.1 Influenza A Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Influenza A Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Influenza A Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Influenza A Vaccine Market
5.7 ESG Ratings of Leading Companies
6 Influenza A Vaccine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Influenza A Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Influenza A Vaccine Market Size Market Share by Type (2020-2025)
6.4 Global Influenza A Vaccine Price by Type (2020-2025)
7 Influenza A Vaccine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Influenza A Vaccine Market Sales by Application (2020-2025)
7.3 Global Influenza A Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Influenza A Vaccine Sales Growth Rate by Application (2020-2025)
8 Influenza A Vaccine Market Sales by Region
8.1 Global Influenza A Vaccine Sales by Region
8.1.1 Global Influenza A Vaccine Sales by Region
8.1.2 Global Influenza A Vaccine Sales Market Share by Region
8.2 Global Influenza A Vaccine Market Size by Region
8.2.1 Global Influenza A Vaccine Market Size by Region
8.2.2 Global Influenza A Vaccine Market Size Market Share by Region
8.3 North America
8.3.1 North America Influenza A Vaccine Sales by Country
8.3.2 North America Influenza A Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Influenza A Vaccine Sales by Country
8.4.2 Europe Influenza A Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Influenza A Vaccine Sales by Region
8.5.2 Asia Pacific Influenza A Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Influenza A Vaccine Sales by Country
8.6.2 South America Influenza A Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Influenza A Vaccine Sales by Region
8.7.2 Middle East and Africa Influenza A Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 Influenza A Vaccine Market Production by Region
9.1 Global Production of Influenza A Vaccine by Region(2020-2025)
9.2 Global Influenza A Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Influenza A Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Influenza A Vaccine Production
9.4.1 North America Influenza A Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Influenza A Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Influenza A Vaccine Production
9.5.1 Europe Influenza A Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Influenza A Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Influenza A Vaccine Production (2020-2025)
9.6.1 Japan Influenza A Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Influenza A Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Influenza A Vaccine Production (2020-2025)
9.7.1 China Influenza A Vaccine Production Growth Rate (2020-2025)
9.7.2 China Influenza A Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 Key Companies Profile
10.1 Novartis
10.1.1 Novartis Basic Information
10.1.2 Novartis Influenza A Vaccine Product Overview
10.1.3 Novartis Influenza A Vaccine Product Market Performance
10.1.4 Novartis Business Overview
10.1.5 Novartis SWOT Analysis
10.1.6 Novartis Recent Developments
10.2 Sanofi
10.2.1 Sanofi Basic Information
10.2.2 Sanofi Influenza A Vaccine Product Overview
10.2.3 Sanofi Influenza A Vaccine Product Market Performance
10.2.4 Sanofi Business Overview
10.2.5 Sanofi SWOT Analysis
10.2.6 Sanofi Recent Developments
10.3 GSK
10.3.1 GSK Basic Information
10.3.2 GSK Influenza A Vaccine Product Overview
10.3.3 GSK Influenza A Vaccine Product Market Performance
10.3.4 GSK Business Overview
10.3.5 GSK SWOT Analysis
10.3.6 GSK Recent Developments
10.4 Medimmune
10.4.1 Medimmune Basic Information
10.4.2 Medimmune Influenza A Vaccine Product Overview
10.4.3 Medimmune Influenza A Vaccine Product Market Performance
10.4.4 Medimmune Business Overview
10.4.5 Medimmune Recent Developments
10.5 Abbott
10.5.1 Abbott Basic Information
10.5.2 Abbott Influenza A Vaccine Product Overview
10.5.3 Abbott Influenza A Vaccine Product Market Performance
10.5.4 Abbott Business Overview
10.5.5 Abbott Recent Developments
10.6 Mitsubishi Tanabe Pharma
10.6.1 Mitsubishi Tanabe Pharma Basic Information
10.6.2 Mitsubishi Tanabe Pharma Influenza A Vaccine Product Overview
10.6.3 Mitsubishi Tanabe Pharma Influenza A Vaccine Product Market Performance
10.6.4 Mitsubishi Tanabe Pharma Business Overview
10.6.5 Mitsubishi Tanabe Pharma Recent Developments
10.7 Merck
10.7.1 Merck Basic Information
10.7.2 Merck Influenza A Vaccine Product Overview
10.7.3 Merck Influenza A Vaccine Product Market Performance
10.7.4 Merck Business Overview
10.7.5 Merck Recent Developments
10.8 Sinovac Biotech
10.8.1 Sinovac Biotech Basic Information
10.8.2 Sinovac Biotech Influenza A Vaccine Product Overview
10.8.3 Sinovac Biotech Influenza A Vaccine Product Market Performance
10.8.4 Sinovac Biotech Business Overview
10.8.5 Sinovac Biotech Recent Developments
10.9 Hualan Biological Engineering
10.9.1 Hualan Biological Engineering Basic Information
10.9.2 Hualan Biological Engineering Influenza A Vaccine Product Overview
10.9.3 Hualan Biological Engineering Influenza A Vaccine Product Market Performance
10.9.4 Hualan Biological Engineering Business Overview
10.9.5 Hualan Biological Engineering Recent Developments
10.10 Changsheng Bio-Technology
10.10.1 Changsheng Bio-Technology Basic Information
10.10.2 Changsheng Bio-Technology Influenza A Vaccine Product Overview
10.10.3 Changsheng Bio-Technology Influenza A Vaccine Product Market Performance
10.10.4 Changsheng Bio-Technology Business Overview
10.10.5 Changsheng Bio-Technology Recent Developments
10.11 Beijing Tiantan Bio-Products
10.11.1 Beijing Tiantan Bio-Products Basic Information
10.11.2 Beijing Tiantan Bio-Products Influenza A Vaccine Product Overview
10.11.3 Beijing Tiantan Bio-Products Influenza A Vaccine Product Market Performance
10.11.4 Beijing Tiantan Bio-Products Business Overview
10.11.5 Beijing Tiantan Bio-Products Recent Developments
11 Influenza A Vaccine Market Forecast by Region
11.1 Global Influenza A Vaccine Market Size Forecast
11.2 Global Influenza A Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Influenza A Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Influenza A Vaccine Market Size Forecast by Region
11.2.4 South America Influenza A Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Influenza A Vaccine by Country
12 Forecast Market by Type and by Application (2026-2033)
12.1 Global Influenza A Vaccine Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Influenza A Vaccine by Type (2026-2033)
12.1.2 Global Influenza A Vaccine Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Influenza A Vaccine by Type (2026-2033)
12.2 Global Influenza A Vaccine Market Forecast by Application (2026-2033)
12.2.1 Global Influenza A Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Influenza A Vaccine Market Size (M USD) Forecast by Application (2026-2033)
13 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Influenza A Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Influenza A Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Influenza A Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Influenza A Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Influenza A Vaccine Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza A Vaccine as of 2024)
Table 10. Global Market Influenza A Vaccine Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Influenza A Vaccine Manufacturing Sites and Area Served
Table 12. Manufacturers Influenza A Vaccine Product Type
Table 13. Global Influenza A Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Influenza A Vaccine Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Influenza A Vaccine Sales by Type (K MT)
Table 25. Global Influenza A Vaccine Market Size by Type (M USD)
Table 26. Global Influenza A Vaccine Sales (K MT) by Type (2020-2025)
Table 27. Global Influenza A Vaccine Sales Market Share by Type (2020-2025)
Table 28. Global Influenza A Vaccine Market Size (M USD) by Type (2020-2025)
Table 29. Global Influenza A Vaccine Market Size Share by Type (2020-2025)
Table 30. Global Influenza A Vaccine Price (USD/MT) by Type (2020-2025)
Table 31. Global Influenza A Vaccine Sales (K MT) by Application
Table 32. Global Influenza A Vaccine Market Size by Application
Table 33. Global Influenza A Vaccine Sales by Application (2020-2025) & (K MT)
Table 34. Global Influenza A Vaccine Sales Market Share by Application (2020-2025)
Table 35. Global Influenza A Vaccine Market Size by Application (2020-2025) & (M USD)
Table 36. Global Influenza A Vaccine Market Share by Application (2020-2025)
Table 37. Global Influenza A Vaccine Sales Growth Rate by Application (2020-2025)
Table 38. Global Influenza A Vaccine Sales by Region (2020-2025) & (K MT)
Table 39. Global Influenza A Vaccine Sales Market Share by Region (2020-2025)
Table 40. Global Influenza A Vaccine Market Size by Region (2020-2025) & (M USD)
Table 41. Global Influenza A Vaccine Market Size Market Share by Region (2020-2025)
Table 42. North America Influenza A Vaccine Sales by Country (2020-2025) & (K MT)
Table 43. North America Influenza A Vaccine Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Influenza A Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. Europe Influenza A Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Influenza A Vaccine Sales by Region (2020-2025) & (K MT)
Table 47. Asia Pacific Influenza A Vaccine Market Size by Region (2020-2025) & (M USD)
Table 48. South America Influenza A Vaccine Sales by Country (2020-2025) & (K MT)
Table 49. South America Influenza A Vaccine Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Influenza A Vaccine Sales by Region (2020-2025) & (K MT)
Table 51. Middle East and Africa Influenza A Vaccine Market Size by Region (2020-2025) & (M USD)
Table 52. Global Influenza A Vaccine Production (K MT) by Region(2020-2025)
Table 53. Global Influenza A Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Influenza A Vaccine Revenue Market Share by Region (2020-2025)
Table 55. Global Influenza A Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 56. North America Influenza A Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 57. Europe Influenza A Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 58. Japan Influenza A Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 59. China Influenza A Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 60. Novartis Basic Information
Table 61. Novartis Influenza A Vaccine Product Overview
Table 62. Novartis Influenza A Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 63. Novartis Business Overview
Table 64. Novartis SWOT Analysis
Table 65. Novartis Recent Developments
Table 66. Sanofi Basic Information
Table 67. Sanofi Influenza A Vaccine Product Overview
Table 68. Sanofi Influenza A Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 69. Sanofi Business Overview
Table 70. Sanofi SWOT Analysis
Table 71. Sanofi Recent Developments
Table 72. GSK Basic Information
Table 73. GSK Influenza A Vaccine Product Overview
Table 74. GSK Influenza A Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. GSK Business Overview
Table 76. GSK SWOT Analysis
Table 77. GSK Recent Developments
Table 78. Medimmune Basic Information
Table 79. Medimmune Influenza A Vaccine Product Overview
Table 80. Medimmune Influenza A Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 81. Medimmune Business Overview
Table 82. Medimmune Recent Developments
Table 83. Abbott Basic Information
Table 84. Abbott Influenza A Vaccine Product Overview
Table 85. Abbott Influenza A Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Abbott Business Overview
Table 87. Abbott Recent Developments
Table 88. Mitsubishi Tanabe Pharma Basic Information
Table 89. Mitsubishi Tanabe Pharma Influenza A Vaccine Product Overview
Table 90. Mitsubishi Tanabe Pharma Influenza A Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 91. Mitsubishi Tanabe Pharma Business Overview
Table 92. Mitsubishi Tanabe Pharma Recent Developments
Table 93. Merck Basic Information
Table 94. Merck Influenza A Vaccine Product Overview
Table 95. Merck Influenza A Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 96. Merck Business Overview
Table 97. Merck Recent Developments
Table 98. Sinovac Biotech Basic Information
Table 99. Sinovac Biotech Influenza A Vaccine Product Overview
Table 100. Sinovac Biotech Influenza A Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 101. Sinovac Biotech Business Overview
Table 102. Sinovac Biotech Recent Developments
Table 103. Hualan Biological Engineering Basic Information
Table 104. Hualan Biological Engineering Influenza A Vaccine Product Overview
Table 105. Hualan Biological Engineering Influenza A Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 106. Hualan Biological Engineering Business Overview
Table 107. Hualan Biological Engineering Recent Developments
Table 108. Changsheng Bio-Technology Basic Information
Table 109. Changsheng Bio-Technology Influenza A Vaccine Product Overview
Table 110. Changsheng Bio-Technology Influenza A Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 111. Changsheng Bio-Technology Business Overview
Table 112. Changsheng Bio-Technology Recent Developments
Table 113. Beijing Tiantan Bio-Products Basic Information
Table 114. Beijing Tiantan Bio-Products Influenza A Vaccine Product Overview
Table 115. Beijing Tiantan Bio-Products Influenza A Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Beijing Tiantan Bio-Products Business Overview
Table 117. Beijing Tiantan Bio-Products Recent Developments
Table 118. Global Influenza A Vaccine Sales Forecast by Region (2026-2033) & (K MT)
Table 119. Global Influenza A Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 120. North America Influenza A Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 121. North America Influenza A Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 122. Europe Influenza A Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 123. Europe Influenza A Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 124. Asia Pacific Influenza A Vaccine Sales Forecast by Region (2026-2033) & (K MT)
Table 125. Asia Pacific Influenza A Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 126. South America Influenza A Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 127. South America Influenza A Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 128. Middle East and Africa Influenza A Vaccine Sales Forecast by Country (2026-2033) & (Units)
Table 129. Middle East and Africa Influenza A Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 130. Global Influenza A Vaccine Sales Forecast by Type (2026-2033) & (K MT)
Table 131. Global Influenza A Vaccine Market Size Forecast by Type (2026-2033) & (M USD)
Table 132. Global Influenza A Vaccine Price Forecast by Type (2026-2033) & (USD/MT)
Table 133. Global Influenza A Vaccine Sales (K MT) Forecast by Application (2026-2033)
Table 134. Global Influenza A Vaccine Market Size Forecast by Application (2026-2033) & (M USD)
List of Figures
Figure 1. Product Picture of Influenza A Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Influenza A Vaccine Market Size (M USD), 2024-2033
Figure 5. Global Influenza A Vaccine Market Size (M USD) (2020-2033)
Figure 6. Global Influenza A Vaccine Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Influenza A Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Influenza A Vaccine Product Life Cycle
Figure 13. Influenza A Vaccine Sales Share by Manufacturers in 2024
Figure 14. Global Influenza A Vaccine Revenue Share by Manufacturers in 2024
Figure 15. Influenza A Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Influenza A Vaccine Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Influenza A Vaccine Revenue in 2024
Figure 18. Industry Chain Map of Influenza A Vaccine
Figure 19. Global Influenza A Vaccine Market PEST Analysis
Figure 20. Global Influenza A Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Influenza A Vaccine Market Share by Type
Figure 27. Sales Market Share of Influenza A Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Influenza A Vaccine by Type in 2024
Figure 29. Market Size Share of Influenza A Vaccine by Type (2020-2025)
Figure 30. Market Size Share of Influenza A Vaccine by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Influenza A Vaccine Market Share by Application
Figure 33. Global Influenza A Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Influenza A Vaccine Sales Market Share by Application in 2024
Figure 35. Global Influenza A Vaccine Market Share by Application (2020-2025)
Figure 36. Global Influenza A Vaccine Market Share by Application in 2024
Figure 37. Global Influenza A Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Influenza A Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Influenza A Vaccine Market Size Market Share by Region (2020-2025)
Figure 40. North America Influenza A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Influenza A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Influenza A Vaccine Sales Market Share by Country in 2024
Figure 43. North America Influenza A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Influenza A Vaccine Market Size Market Share by Country in 2024
Figure 45. U.S. Influenza A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Influenza A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Influenza A Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Influenza A Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Influenza A Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Influenza A Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Influenza A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Influenza A Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Influenza A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Influenza A Vaccine Market Size Market Share by Country in 2024
Figure 55. Germany Influenza A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Influenza A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Influenza A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Influenza A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Influenza A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Influenza A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Influenza A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Influenza A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Influenza A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Influenza A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Influenza A Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Influenza A Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Influenza A Vaccine Market Size Market Share by Region in 2024
Figure 68. China Influenza A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Influenza A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Influenza A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Influenza A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Influenza A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Influenza A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Influenza A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Influenza A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Influenza A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Influenza A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Influenza A Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Influenza A Vaccine Sales Market Share by Country in 2024
Figure 80. South America Influenza A Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Influenza A Vaccine Market Size Market Share by Country in 2024
Figure 82. Brazil Influenza A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Influenza A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Influenza A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Influenza A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Influenza A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Influenza A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Influenza A Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Influenza A Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Influenza A Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Influenza A Vaccine Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Influenza A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Influenza A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Influenza A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Influenza A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Influenza A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Influenza A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Influenza A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Influenza A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Influenza A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Influenza A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Influenza A Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Influenza A Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Influenza A Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Influenza A Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Influenza A Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Influenza A Vaccine Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Influenza A Vaccine Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Influenza A Vaccine Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Influenza A Vaccine Market Share Forecast by Type (2026-2033)
Figure 111. Global Influenza A Vaccine Sales Forecast by Application (2026-2033)
Figure 112. Global Influenza A Vaccine Market Share Forecast by Application (2026-2033)